信隆健康:2025一季报净利润-0.02亿 同比下降200%

Financial Performance - The company reported a basic earnings per share of -0.0060 yuan for Q1 2025, a decrease of 185.71% compared to 0.0070 yuan in Q1 2024 [1] - The net profit for Q1 2025 was -0.02 billion yuan, representing a 200% decline from 0.02 billion yuan in Q1 2024 [1] - The return on equity (ROE) was -0.25% in Q1 2025, down 192.59% from 0.27% in Q1 2024 [1] - Revenue increased to 3.06 billion yuan in Q1 2025, a growth of 27.5% compared to 2.4 billion yuan in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 19,229.68 million shares, accounting for 52.76% of the circulating shares, with a decrease of 1,256.16 million shares from the previous period [1] - The largest shareholder, Litian Development Co., Ltd., holds 15,452.25 million shares, representing 42.40% of the total share capital, with no change [2] - New entrants among the top shareholders include Gong Yonghu, Wang Fengqin, and Liao Jun, each holding less than 1% of the total shares [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [3]